Advertisement

Current Issue – 2020 – Volume 23.1

23.1

Recent Advances in the Treatment and Management of Moderate-to-Severe Atopic Dermatitis:What’s New in Biologic Therapies

 

Expanding Options in the Treatment of Prostate Cancer:The Impact of Prognostic Biomarkers on Patient Outcomes. New Advances in the Diagnosis and Treatment of Narcolepsy

READ FULL JOURNAL >>

ARTICLES

23.1-F1

Advances in Management of Acute Coronary Syndrome (ACS): Guideline Recommendations for Novel Treatments in Dual Antiplatelet Therapy

23.1-F2

Novel Treatment Advances and Approaches in Acute Myeloid Leukemia (AML):Expert Strategies for Improved Clinical and Economic Outcomes

23.1-F3

Optimizing Switching and Sequencing Strategies for Improved Clinical and Economic Outcomes in the Management of Multiple Sclerosis

23.1-F4

Improving Clinical and Economic Outcomes with Personalized Treatment in the Management of Advanced Non-Small Cell Lung Cancer (NSCLC)

23.1-F5

Exploring New Pathways and Emerging Data for Better Control and Management in the Personalized Treatment of Severe Asthma

23.1-F6

Exploring the Evolving Treatment Paradigm in the Managementof Inflammatory Bowel Disease

23.1-F7

Optimizing Clinical and Economic Outcomes in the Management of Moderate-to-Severe Rheumatoid Arthritis

23.1-F8

Recent Advances in the Treatment and Management of Moderate-to-SevereAtopic Dermatitis: What’s New in Biologic Therapies

23.1-F9

Expanding Options in the Treatment of Prostate Cancer: The Impact of Prognostic Biomarkers on Patient Outcomes

23.1-F11

Expanding the Role of Biosimilars:Key Advances in the Treatment Landscape

23.1-F11

New Advances in the Diagnosis and Treatment of Narcolepsy

23.1-F12

Integrating New and Emerging Targeted Therapy into the Treatment of Ovarian Cancer: Expert Strategies for Improved Patient Outcomes

23.1-F13

Evolving Considerations in the Treatment of Metastatic Bladder Cancer:A Closer Look at the Role of Immunotherapy

23.1-F14

Individualizing Treatment in the Management of Advanced Breast Cancer: How Novel Therapies are Changing the Treatment Paradigm

23.1-F15

Novel Treatment Advances and Approaches in the Management of Hepatocellular Carcinoma (HCC): Expert Strategies for Improved Patient Outcomes